199 related articles for article (PubMed ID: 21268237)
1. In vitro and in vivo degradation of poly(D, L-lactide-co-glycolide)/amorphous calcium phosphate copolymer coated on metal stents.
Ma X; Oyamada S; Wu T; Robich MP; Wu H; Wang X; Buchholz B; McCarthy S; Bianchi CF; Sellke FW; Laham R
J Biomed Mater Res A; 2011 Mar; 96(4):632-8. PubMed ID: 21268237
[TBL] [Abstract][Full Text] [Related]
2. Improved biocompatibility of poly(lactic-co-glycolic acid) orv and poly-L-lactic acid blended with nanoparticulate amorphous calcium phosphate in vascular stent applications.
Zheng X; Wang Y; Lan Z; Lyu Y; Feng G; Zhang Y; Tagusari S; Kislauskis E; Robich MP; McCarthy S; Sellke FW; Laham R; Jiang X; Gu WW; Wu T
J Biomed Nanotechnol; 2014 Jun; 10(6):900-10. PubMed ID: 24749387
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies.
Ma X; Oyamada S; Gao F; Wu T; Robich MP; Wu H; Wang X; Buchholz B; McCarthy S; Gu Z; Bianchi CF; Sellke FW; Laham R
J Pharm Biomed Anal; 2011 Mar; 54(4):807-11. PubMed ID: 21126843
[TBL] [Abstract][Full Text] [Related]
4. Size effect of calcium phosphate coated with poly-DL-lactide- co-glycolide on healing processes in bone reconstruction.
Ignjatovic NL; Ajdukovic ZR; Savic VP; Uskokovic DP
J Biomed Mater Res B Appl Biomater; 2010 Jul; 94(1):108-17. PubMed ID: 20524184
[TBL] [Abstract][Full Text] [Related]
5. In-patient versus in vitro degradation of P(L/DL)LA and PLGA.
Landes CA; Ballon A; Roth C
J Biomed Mater Res B Appl Biomater; 2006 Feb; 76(2):403-11. PubMed ID: 16184534
[TBL] [Abstract][Full Text] [Related]
6. Calcium phosphate/poly(D,L-lactic-co-glycolic acid) composite bone substitute materials: evaluation of temporal degradation and bone ingrowth in a rat critical-sized cranial defect.
van de Watering FCJ; van den Beucken JJJP; Walboomers XF; Jansen JA
Clin Oral Implants Res; 2012 Feb; 23(2):151-159. PubMed ID: 21631594
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents.
Xi T; Gao R; Xu B; Chen L; Luo T; Liu J; Wei Y; Zhong S
Biomaterials; 2010 Jul; 31(19):5151-8. PubMed ID: 20382420
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro.
Tracy MA; Ward KL; Firouzabadian L; Wang Y; Dong N; Qian R; Zhang Y
Biomaterials; 1999 Jun; 20(11):1057-62. PubMed ID: 10378806
[TBL] [Abstract][Full Text] [Related]
9. A novel in vitro release technique for peptide containing biodegradable microspheres.
Kostanski JW; DeLuca PP
AAPS PharmSciTech; 2000 Mar; 1(1):E4. PubMed ID: 14727853
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
Lu L; Peter SJ; Lyman MD; Lai HL; Leite SM; Tamada JA; Uyama S; Vacanti JP; Langer R; Mikos AG
Biomaterials; 2000 Sep; 21(18):1837-45. PubMed ID: 10919687
[TBL] [Abstract][Full Text] [Related]
11. Fabrication and characterization of poly(DL-lactic-co-glycolic acid)/zirconia-hybridized amorphous calcium phosphate composites.
Whited BM; Goldstein AS; Skrtic D; Love BJ
J Biomater Sci Polym Ed; 2006; 17(4):403-18. PubMed ID: 16768292
[TBL] [Abstract][Full Text] [Related]
12. Novel biodegradable drug-eluting stent composed of poly-L-lactic acid and amorphous calcium phosphate nanoparticles demonstrates improved structural and functional performance for coronary artery disease.
Lan Z; Lyu Y; Xiao J; Zheng X; He S; Feng G; Zhang Y; Wang S; Kislauskis E; Chen J; McCarthy S; Laham R; Jiang X; Wu T
J Biomed Nanotechnol; 2014 Jul; 10(7):1194-204. PubMed ID: 24804540
[TBL] [Abstract][Full Text] [Related]
13. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
Kranz H; Ubrich N; Maincent P; Bodmeier R
J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
[TBL] [Abstract][Full Text] [Related]
14. The effect of particle size on the in vivo degradation of poly(d,l-lactide-co-glycolide)/α-tricalcium phosphate micro- and nanocomposites.
Bennett SM; Arumugam M; Wilberforce S; Enea D; Rushton N; Zhang XC; Best SM; Cameron RE; Brooks RA
Acta Biomater; 2016 Nov; 45():340-348. PubMed ID: 27567963
[TBL] [Abstract][Full Text] [Related]
15. Modeling and analysis of drug-eluting stents with biodegradable PLGA coating: consequences on intravascular drug delivery.
Zhu X; Braatz RD
J Biomech Eng; 2014 Nov; 136(11):1110041-11100410. PubMed ID: 25084767
[TBL] [Abstract][Full Text] [Related]
16. Fabrication and characterization of permeable degradable poly(DL-lactide-co-glycolide) (PLGA) hollow fiber phase inversion membranes for use as nerve tract guidance channels.
Wen X; Tresco PA
Biomaterials; 2006 Jul; 27(20):3800-9. PubMed ID: 16564567
[TBL] [Abstract][Full Text] [Related]
17. Structural and degradation characteristics of an innovative porous PLGA/TCP scaffold incorporated with bioactive molecular icaritin.
Xie XH; Wang XL; Zhang G; He YX; Wang XH; Liu Z; He K; Peng J; Leng Y; Qin L
Biomed Mater; 2010 Oct; 5(5):054109. PubMed ID: 20876954
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of a highly macroporous biodegradable composite tissue engineering scaffold.
Guan L; Davies JE
J Biomed Mater Res A; 2004 Dec; 71(3):480-7. PubMed ID: 15478140
[TBL] [Abstract][Full Text] [Related]
19. Body distribution of poly(D,L-lactide-co-glycolide) copolymer degradation products in rats.
Hua N; Sun J
J Mater Sci Mater Med; 2008 Oct; 19(10):3243-8. PubMed ID: 18470703
[TBL] [Abstract][Full Text] [Related]
20. A mechanistic model for drug release in PLGA biodegradable stent coatings coupled with polymer degradation and erosion.
Zhu X; Braatz RD
J Biomed Mater Res A; 2015 Jul; 103(7):2269-79. PubMed ID: 25345656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
